Northern Trust Corp Buys 55,264 Shares of Amedisys, Inc. (NASDAQ:AMED)

Northern Trust Corp raised its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 23.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 289,228 shares of the health services provider's stock after acquiring an additional 55,264 shares during the quarter. Northern Trust Corp owned approximately 0.88% of Amedisys worth $26,259,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the business. Vazirani Asset Management LLC acquired a new stake in Amedisys during the 4th quarter worth about $908,000. Quarry LP boosted its position in shares of Amedisys by 48.9% during the 4th quarter. Quarry LP now owns 39,647 shares of the health services provider's stock valued at $3,600,000 after purchasing an additional 13,028 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Amedisys during the fourth quarter worth approximately $55,000. Credit Industriel ET Commercial bought a new stake in Amedisys in the fourth quarter worth approximately $3,486,000. Finally, Cigogne Management SA acquired a new position in Amedisys in the fourth quarter valued at approximately $2,692,000. Institutional investors own 94.36% of the company's stock.

Analyst Ratings Changes

AMED has been the subject of several recent analyst reports. Stephens reaffirmed an "equal weight" rating and set a $101.00 price objective on shares of Amedisys in a research report on Tuesday, March 4th. Royal Bank of Canada restated an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Amedisys presently has a consensus rating of "Hold" and an average target price of $100.75.

Amedisys Stock Up 0.2%

Shares of NASDAQ AMED traded up $0.15 during midday trading on Friday, hitting $93.87. 70,520 shares of the stock traded hands, compared to its average volume of 417,596. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95. The business has a 50 day moving average price of $93.16 and a two-hundred day moving average price of $91.66. The company has a market cap of $3.08 billion, a PE ratio of 37.25, a P/E/G ratio of 1.78 and a beta of 0.96.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business had revenue of $594.78 million during the quarter, compared to analyst estimates of $597.43 million. During the same quarter in the previous year, the business posted $1.03 EPS. Amedisys's quarterly revenue was up 4.1% on a year-over-year basis. On average, equities analysts predict that Amedisys, Inc. will post 4.4 EPS for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.